Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1105
Delayed Data
As of 3:59pm ET
 +0.0035 / +3.27%
Today’s Change
0.06
Today|||52-Week Range
0.29
+37.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues40.0K36.0K47.0K23.0K
 
 
 
 
 
Cost of Goods Sold100.0K121.0K221.0K61.0K
 
 
 
 
 
Depreciation And Amortization228.0K251.0K286.0K292.0K
 
 
 
 
 
 
Operating ExpensesGross Income-288.0K-336.0K-460.0K-330.0K
 
 
 
 
 
General Expenses4.3M4.6M4.4M3.7M
 
 
 
 
 
Research And Development2.4M2.7M2.4M2.0M
 
 
 
 
 
Total Operating Expenses4.6M5.0M4.9M4.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M-4.9M-4.9M-4.0M
 
 
 
 
 
Extraordinary Credit13.0K0.000.000.00
 
 
Extraordinary Charge-145.0K--0.00--
 
 
Interest Expense On Debt2.0K2.0K0.001.0K
 
 
 
 
Other Expenses0.001.4M0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.5M-3.4M-4.8M-3.8M
 
 
 
 
 
Net Income-4.5M-3.4M-4.8M-3.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS204.0M213.6M236.1M246.8M
 
 
 
 
 
Shares To Calculate EPS Diluted204.0M213.6M236.1M246.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.02-$0.02-$0.02
 
 
 
 
 
EPS Diluted-$0.02-$0.02-$0.02-$0.02